Aesthetics

From lasers to filler and microneedling, dermatologists have a broad menu of modalities for addressing the challenges of scars.

In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, details the difference between cosmetic moisturizers and pharmaceutical vehicles.

This week, consumer magazines highlight how to treat traction alopecia, the FDA-approval of Winlevi for acne, and more.

This week in aesthetics, we highlight TikTok’s influence on dermatology, a boom in clean beauty, and more.

Nicole Hayre, MD, FAAD, discusses her recent research related to oxytocin's effect on skin aging and how increased levels of oxytocin in the body can make the skin appear younger.

Physicians highlight their favorite products, including skincare with DNA repair, antioxidants, and the introduction of skin wellness.

Joel Schlessinger, MD, and Vivian Bucay, MD, discuss the increased interest in clean beauty, what the term means, and why not all products claiming the moniker live up to the same standards.

Dr. Angelo Landriscina discusses the recent rise and influence of TikTok over the dermatology industry.

This week, consumer magazines highlight Restylane Defyne for Chin augmentation, eyebrow transplants, and more.

This week in aesthetics, we highlight the approval of Restylane Defyne for chin augmentation, Dr. Deborah L. Benzil’s keynote address at the 2021 Women in Cosmetic Surgery event, and more.

Dr. Whitney Bowe explains the link between hyaluronic acid filler and potential COVID-19 vaccine reactions, plus pearls for injectors on how to best keep patients safe.

Galderma announces the FDA-approval of HA dermal filler, Restylane Defyne for use in chin augmentation.

AAFPRS’s 2020 member survey examines the effect of COVID-19 on aesthetic trends, including an increase in surgical procedures, blepharoplasty, and rhinoplasty.

Galderma announces the FDA-approval of HA dermal filler, Restylane Defyne for use in chin augmentation.

Dr. Deborah L. Benzil discusses her keynote address at AACS’s upcoming second annual Women in Cosmetic Surgery event, and uplifting women in medicine.

Soliton announced the FDA has cleared its Rapid Acoustic Pulse (RAP) device for short-term improvement in appearance of cellulite.

This week, consumer magazines highlight COVID-19 vaccine effects attached to dermal filler, hyperpigmentation advice for people of color, and more.

This week in aesthetics, we highlight the launch of Galderma’s “Face for Change” program, Allergan announces the CoolSculpting Elite device and more.

In the final part of our interview with Whitney Bowe, MD, she reveals her tips and tricks for both preventing and minimizing any adverse reactions in her filler patients who might have also received the COVID-19 vaccine.

Candela announces the launch of its Frax Pro system, featuring dual-depth skin resurfacing with both novel Frax 1940 and Frax 1550 applicators.

In part 4 of our interview with Whitney Bowe, MD, she dives into the multiple methods physicians can use to treat adverse reactions from the COVID-19 vaccine in their dermal filler patients.

Recent reports have been surfacing in regard to adverse reactions in dermal fillers patients who have also received the COVID-19 vaccine. Whitney Bowe, MD, New York City, New York, discusses this phenomenon and provides some tips for preventing and treating these side effects.

Allergan announces the launch of Coolsculpting Elite, along with seven new C-shaped applicators.

Allergan Aesthetics plans on expanding its CoolSculpting portfolio with the launch of its novel CoolSculpting Elite device that targets visible fat in nine different areas of the body.

In part 3, Whitney Bowe, MD, suggests how physicians should manage their patients' expectations when it comes to HA fillers and the COVID-19 vaccine.